Effects of transcutaneous tibial nerve stimulation on anorectal physiology in fecal incontinence: a double-blind placebo-controlled cross-over evaluation

被引:11
|
作者
Bouguen, G. [1 ,2 ,3 ]
Ropert, A. [2 ,4 ]
Laine, F. [2 ,5 ]
Pequin, P. [2 ,4 ]
Morcet, J. [2 ,5 ]
Bretagne, J. -F. [1 ,2 ]
Siproudhis, L. [1 ,2 ,3 ]
机构
[1] CHU Pontchaillou, Serv Malad Appareil Digestif, F-35033 Rennes, France
[2] Univ Rennes 1, Rennes, France
[3] Univ Rennes 1, INSERM, U991, Rennes, France
[4] CHU Pontchaillou, Serv Explorat Fonct, F-35033 Rennes, France
[5] CHU Pontchaillou, Unite Invest Clin, F-35033 Rennes, France
来源
NEUROGASTROENTEROLOGY AND MOTILITY | 2014年 / 26卷 / 02期
关键词
fecal incontinence; neuromodulation; physiopathology; transcutaneous electrical nerve stimulation; RECTAL FUNCTION; NEUROMODULATION; ADAPTATION; DISTENSION; EFFICACY; TRIAL;
D O I
10.1111/nmo.12256
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundTranscutaneous electrical tibial nerve stimulation (TENS) is of growing interest for the treatment of fecal incontinence (FI), but its mechanism of action remains uninvestigated. We aimed to further assess the anorectal response to TENS in a dynamic model. MethodsWe performed a placebo-controlled, randomized, double-blinded crossover study in 19 patients suffering from FI to assess the effects of TENS on anorectal function. Anorectal physiology and perception were recorded through two sequences of rectal isobaric distension using an electronic barostat device to measure anal and rectal pressures, rectal volumes, and perception scores. Key ResultsMaximal rectal pressure and volume variation were affected by TENS, with higher mean maximal rectal pressure (5.33 and 4.06mmHg in the active and sham TENS respectively, p<0.0001) and lower volume variation (11.45 and 14.7mL in the active and sham stimulation respectively, p<0.05). Rectal compliance was not modified by active TENS. Pressure of the upper anal canal was significantly lower with raised isobaric distension in sequences assigned to active TENS. Conclusions & InferencesAcute TENS modified anorectal physiology by strengthening the myogenic response to distension rather than increasing muscle relaxation and related rectal compliance in patients with FI.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 50 条
  • [1] Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole
    Borjesson, M
    Rolny, P
    Mannheimer, C
    Pilhall, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) : 1129 - 1135
  • [2] Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study
    Drueke, Barbara
    Baetz, Julia
    Boecker, Maren
    Moeller, Olaf
    Hiemke, Christoph
    Gruender, Gerd
    Gauggel, Siegfried
    PSYCHOPHARMACOLOGY, 2009, 207 (02) : 213 - 223
  • [3] Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study
    Barbara Drueke
    Julia Baetz
    Maren Boecker
    Olaf Moeller
    Christoph Hiemke
    Gerd Gründer
    Siegfried Gauggel
    Psychopharmacology, 2009, 207 : 213 - 223
  • [4] Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    Amiaz, Revital
    Fostick, Leah
    Gershon, Ari
    Zohar, Joseph
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (06) : 455 - 461
  • [5] Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
    Altamura, AC
    Di Rosa, A
    Ermentini, A
    Guaraldi, GP
    Invernizzi, G
    Rudas, N
    Tacchini, G
    Pioli, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 155 - 159
  • [6] Effect of AXOS on fecal water cytotoxicity and genotoxicity: a randomized, double-blind, placebo-controlled, cross-over study
    Windey, Karen
    De Preter, Vicky
    Broekaert, Willem
    Herman, Jean
    Louat, Thierry
    Verbeke, Kristin
    FASEB JOURNAL, 2013, 27
  • [7] DOUBLE-BLIND CROSS-OVER PLACEBO-CONTROLLED STUDY OF OMEPRAZOLE IN THE TREATMENT OF THE SENSITIVE ESOPHAGUS
    WATSON, RGP
    THAM, TCK
    JOHNSTON, BT
    GASTROENTEROLOGY, 1995, 108 (04) : A255 - A255
  • [8] CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY
    HEIMANS, JJ
    DRUKARCH, B
    MATTHAEI, I
    IJFF, GA
    BERTELSMANN, FW
    STRIJERS, RLM
    NAUTA, J
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (06): : 483 - 486
  • [9] Dapsone in Behcet's disease: A double-blind, placebo-controlled, cross-over study
    Sharquie, KE
    Najim, RA
    Abu-Raghif, AR
    JOURNAL OF DERMATOLOGY, 2002, 29 (05): : 267 - 279
  • [10] ENOXIMONE IN CHRONIC STABLE ANGINA - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    DUBREY, SW
    GNANASAKTHY, A
    STEIN, WK
    SONG, JG
    HARDMAN, T
    HYND, J
    NOBLE, MIM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (04) : 532 - 538